| Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More | Frank Vinluan | 08/28/20 | National |
| Seres Sets Sights on FDA After C. Diff Microbiome Therapy Scores in Phase 3 | Frank Vinluan | 08/10/20 | Boston |
| Moderna, Pfizer Protocols May Make COVID Vaccines Hard to Compare | Sarah Karlin-Smith | 08/07/20 | National |
| Dewpoint, Merck Team Up to Tackle HIV Using Condensate Know-How | Sarah de Crescenzo | 07/15/20 | Boston |
| Akili Interactive’s Video Game for ADHD Gets the FDA All Clear | Frank Vinluan | 06/15/20 | Boston |
| Antibiotic Development: HHS Not Yet Sold on “Pull” Incentives | Sarah Karlin-Smith | 05/16/20 | National |
| Pfizer Pays Valneva $130M for a Bite at a Lyme Disease Vaccine | Frank Vinluan | 05/01/20 | Europe |
| Global Blood’s Sickle Cell Drug Wins FDA Approval Ahead of Schedule | Frank Vinluan | 11/25/19 | San Francisco |
| Daré to Add Microchip-Based Birth Control to Women’s Health Portfolio | Sarah de Crescenzo | 11/15/19 | San Diego |
| Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More | Frank Vinluan | 11/08/19 | National |
| Icosavax Lands $51M to Bring Vaccine for Respiratory Virus to Clinic | Frank Vinluan | 10/03/19 | Seattle |
| Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More | Frank Vinluan | 09/27/19 | National |
| Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More | Frank Vinluan | 08/23/19 | National |
| With Yale Tech and $12M, Artizan Aims for Root Cause of Gut Disease | Frank Vinluan | 06/10/19 | Boston |
| Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More | Frank Vinluan | 05/31/19 | National |
| SuperNus ADHD Drug to Head to FDA, But Is It Better Than a Generic? | Frank Vinluan | 12/06/18 | National |
| How Blockchain Is Finding a Place at Your Thanksgiving Table | Frank Vinluan | 11/20/18 | Raleigh Durham |
| Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More | Frank Vinluan | 11/16/18 | National |
| InCarda Breathes In $42M for Clinical Tests of Inhalable Heart Drug | Frank Vinluan | 11/08/18 | San Francisco |
| Paratek Wins Two FDA Drug Approvals for Three Conditions in Same Day | Frank Vinluan | 10/03/18 | Boston |
| Alexion Hits Study Goals, Could Expand Blockbuster Drug to CNS | Frank Vinluan | 09/24/18 | Boston |
| NIH Using Vaccines from Madison Startup FluGen in New Clinical Trial | Jeff Buchanan | 09/19/18 | Wisconsin |
| Gilead Partners with Precision Bio in Search of Gene-Editing HBV Cure | Frank Vinluan | 09/12/18 | San Francisco |
| SnappyScreen’s Booths Protect People While They Have Fun in the Sun | Angela Shah | 07/24/18 | National |
| Student-Entrepreneur from Wisconsin Named 2018 Thiel Fellow | Jeff Buchanan | 06/26/18 | Wisconsin |
| Zurex Pharma Raises $9M to Fight Hospital-Acquired Infections | Jeff Buchanan | 06/12/18 | Wisconsin |
| FluGen to Study Versatility of Its Universal Flu Vaccine Candidate | Jeff Buchanan | 05/17/18 | Wisconsin |
| Bio Roundup: Ex-Kiters Say Allo, NASH Cash & Data, Alkermes No & More | Alex Lash | 04/06/18 | National |
| EnsoData Raises $1.5M to Develop A.I.-powered Sleep Analysis Tools | Jeff Buchanan | 03/06/18 | Wisconsin |
| Exact Sciences: Severe Flu Season Slows Down Cancer Test’s Sales | Jeff Buchanan | 02/26/18 | Wisconsin |
